Halogen-Kupfer-Austausch mit Kupferhypersilanid und Organylhalogeniden

Die Reaktion von Kupfertris(trimathylsilyl)silan (= Hypersilylkupfer, CuHyp) mit Iodoorganylverbindungen sollte analog zum Ullmann-Protokoll zum Halogen-Nukleophil-Austausch führen. Tatsächlich beobachteten wir zumeist die Bildung von Cuprio-Organylen, isolierbar in Form von mehrkernigen Neutralkomplexen aus dem Produkt und weiteren Äquivalenten von Hypersilylkupfer. Nach Zugabe von (weichen) Basen wie Trimethylphosphan kam es zur Auflösung dieser Komplexe und zur Bildung der erwarteten Silylorganyle. Von der systematischen Variation der eingesetzten Arene, Alkene und Alkine sowie ihrer Liganden versprachen wir uns tiefere Einsicht in die mechanistischen Zusammenhänge. Neben dem üblichen Halogen-Kupfer-Autausch konnten wir bei orthosubstituierten, bzw. zusätzlich tetramethylsubstituierten Diiodarenen einen einfachen Iod-Siyl-Autausch beobachten (vermutlich über Arinzwischenstufen), für Alkinedukte sogar eine doppelte Silylierung. Tatsächlich zeigen quantenchemische Berechnungen für CuHyp-Iodoorganyl-Systeme eine klare Präferenz von ullmannartigen Verläufen; andererseits führte Basenzugabe erst nachträglich zur Bildung von Ullmann-Produkten über die Auflösung der primären Komplexe. Innerhalb der üblicherweise gebildeten mehrkernigen Komplexe kommen Bindungen durch die Wechselwirkung unbesetzter σ*-Molekülorbitalee am Kupferzentrum von CuHyp und elektronenreichen bindenden Orbitalen in den Kupferorganyleinheiten zustande. Freie Elektronenpaare am Phosphor bei PMe3 könnten analog die Auflösung der Neutralkomplexe und die Bildung von vierkernigen Kupfer(III)-Intermediaten zwischen den Kupferorganyleinheiten und Iodsilan in der Lösung bewirken, die aufgrund ihrer strukturellen und energetischen Besonderheiten zu den erwarteten Ullmann-Produkten weiterreagieren würden. Die beobachteten Primärreaktionen verliefen dann offensichtlich über vergleichbare, aber unterschiedlich strukturierte Intermediate, vermutlich aufgrund der Tatsache, dass das eingesetzte CuHyp als Trimer vorliegt. Diese Annahme wird durch die direkte Silylierung von Iodalkinen gestützt, deren Dreifachbindungen möglicherweise als interne Base die trimeren in monomere CuHyp-Einheiten überführen. In eine ähnliche Richtung wäre die jüngst berichtete direkte Silylierung von Allylen bei Anwesenheit von elektronenreichen CN-Gruppen zu deuten.

Experimental Infection of Bats with Geomyces destructans Causes White-nose Syndrome

White-nose syndrome (WNS) has caused recent catastrophic declines among multiple species of bats in eastern North America1, 2. The disease’s name derives from a visually apparent white growth of the newly discovered fungus Geomyces destructans on the skin (including the muzzle) of hibernating bats1, 3. Colonization of skin by this fungus is associated with characteristic cutaneous lesions that are the only consistent pathological finding related to WNS4. However, the role of G. destructans in WNS remains controversial because evidence to implicate the fungus as the primary cause of this disease is lacking. The debate is fuelled, in part, by the assumption that fungal infections in mammals are most commonly associated with immune system dysfunction5, 6, 7. Additionally, the recent discovery that G. destructans commonly colonizes the skin of bats of Europe, where no unusual bat mortality events have been reported8, 9, 10, has generated further speculation that the fungus is an opportunistic pathogen and that other unidentified factors are the primary cause of WNS11, 12. Here we demonstrate that exposure of healthy little brown bats (Myotis lucifugus) to pure cultures of G. destructans causes WNS. Live G. destructans was subsequently cultured from diseased bats, successfully fulfilling established criteria for the determination ofG. destructans as a primary pathogen13. We also confirmed that WNS can be transmitted from infected bats to healthy bats through direct contact. Our results provide the first direct evidence that G. destructans is the causal agent of WNS and that the recent emergence of WNS in North America may represent translocation of the fungus to a region with a naive population of animals8. Demonstration of causality is an instrumental step in elucidating the pathogenesis14 and epidemiology15 of WNS and in guiding management actions to preserve bat populations against the novel threat posed by this devastating infectious disease.

Electrolyte Depletion in White-nose Syndrome Bats

The emerging wildlife disease white-nose syndrome is causing widespread mortality in hibernating North American bats. White-nose syndrome occurs when the fungus Geomyces destructans infects the living skin of bats during hibernation, but links between infection and mortality are underexplored. We analyzed blood from hibernating bats and compared blood electrolyte levels to wing damage caused by the fungus. Sodium and chloride tended to decrease as wing damage increased in severity. Depletion of these electrolytes suggests that infected bats may become hypotonically dehydrated during winter. Although bats regularly arouse from hibernation to drink during winter, water available in hibernacula may not contain sufficient electrolytes to offset winter losses caused by disease. Damage to bat wings from G. destructans may cause life-threatening electrolyte imbalances.

Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial

BACKGROUND Idiopathic pulmonary fibrosis (IPF) is characterized by formation and proliferation of fibroblast foci. Endothelin-1 induces lung fibroblast proliferation and contractile activity via the endothelin A (ETA) receptor. OBJECTIVE To determine whether ambrisentan, an ETA receptor-selective antagonist, reduces the rate of IPF progression. DESIGN Randomized, double-blind, placebo-controlled, event-driven trial. (ClinicalTrials.gov: NCT00768300). SETTING Academic and private hospitals. PARTICIPANTS Patients with IPF aged 40 to 80 years with minimal or no honeycombing on high-resolution computed tomography scans. INTERVENTION Ambrisentan, 10 mg/d, or placebo. MEASUREMENTS Time to disease progression, defined as death, respiratory hospitalization, or a categorical decrease in lung function. RESULTS The study was terminated after enrollment of 492 patients (75% of intended enrollment; mean duration of exposure to study medication, 34.7 weeks) because an interim analysis indicated a low likelihood of showing efficacy for the end point by the scheduled end of the study. Ambrisentan-treated patients were more likely to meet the prespecified criteria for disease progression (90 [27.4%] vs. 28 [17.2%] patients; P = 0.010; hazard ratio, 1.74 [95% CI, 1.14 to 2.66]). Lung function decline was seen in 55 (16.7%) ambrisentan-treated patients and 19 (11.7%) placebo-treated patients (P = 0.109). Respiratory hospitalizations were seen in 44 (13.4%) and 9 (5.5%) patients in the ambrisentan and placebo groups, respectively (P = 0.007). Twenty-six (7.9%) patients who received ambrisentan and 6 (3.7%) who received placebo died (P = 0.100). Thirty-two (10%) ambrisentan-treated patients and 16 (10%) placebo-treated patients had pulmonary hypertension at baseline, and analysis stratified by the presence of pulmonary hypertension revealed similar results for the primary end point. LIMITATION The study was terminated early. CONCLUSION Ambrisentan was not effective in treating IPF and may be associated with an increased risk for disease progression and respiratory hospitalizations. PRIMARY FUNDING SOURCE Gilead Sciences.

In vitro fabrication of autologous living tissue-engineered vascular grafts based on prenatally harvested ovine amniotic fluid-derived stem cells

Amniotic fluid cells (AFCs) have been proposed as a valuable source for tissue engineering and regenerative medicine. However, before clinical implementation, rigorous evaluation of this cell source in clinically relevant animal models accepted by regulatory authorities is indispensable. Today, the ovine model represents one of the most accepted preclinical animal models, in particular for cardiovascular applications. Here, we investigate the isolation and use of autologous ovine AFCs as cell source for cardiovascular tissue engineering applications. Fetal fluids were aspirated in vivo from pregnant ewes (n = 9) and from explanted uteri post mortem at different gestational ages (n = 91). Amniotic non-allantoic fluid nature was evaluated biochemically and in vivo samples were compared with post mortem reference samples. Isolated cells revealed an immunohistochemical phenotype similar to ovine bone marrow-derived mesenchymal stem cells (MSCs) and showed expression of stem cell factors described for embryonic stem cells, such as NANOG and STAT-3. Isolated ovine amniotic fluid-derived MSCs were screened for numeric chromosomal aberrations and successfully differentiated into several mesodermal phenotypes. Myofibroblastic ovine AFC lineages were then successfully used for the in vitro fabrication of small- and large-diameter tissue-engineered vascular grafts (n = 10) and cardiovascular patches (n = 34), laying the foundation for the use of this relevant pre-clinical in vivo assessment model for future amniotic fluid cell-based therapeutic applications. Copyright © 2013 John Wiley & Sons, Ltd.

Beleuchtung zweyer Lehrbücher über Religions-Unterricht der Israeliten

von Alexander Behr

Die Religionsprincipien des reformirten Judenthums entworfen und den Reformgenossenschaften zur Prüfung und Annahme empfohlen

von S. Holdheim

Lehrbuch der mosaischen Religion

bearb. von Alexander Behr unter Aufsicht d. Abraham Bing. Geprüft u. anerkannt vom Rabbinate zu Fürth ...

Genetic association study of QT interval highlights role for calcium signaling pathways in myocardial repolarization

The QT interval, an electrocardiographic measure reflecting myocardial repolarization, is a heritable trait. QT prolongation is a risk factor for ventricular arrhythmias and sudden cardiac death (SCD) and could indicate the presence of the potentially lethal mendelian long-QT syndrome (LQTS). Using a genome-wide association and replication study in up to 100,000 individuals, we identified 35 common variant loci associated with QT interval that collectively explain ∼8-10% of QT-interval variation and highlight the importance of calcium regulation in myocardial repolarization. Rare variant analysis of 6 new QT interval-associated loci in 298 unrelated probands with LQTS identified coding variants not found in controls but of uncertain causality and therefore requiring validation. Several newly identified loci encode proteins that physically interact with other recognized repolarization proteins. Our integration of common variant association, expression and orthogonal protein-protein interaction screens provides new insights into cardiac electrophysiology and identifies new candidate genes for ventricular arrhythmias, LQTS and SCD.